RFP
GILD icon

Root Financial Partners’s Gilead Sciences GILD Stock Holding History

Root Financial Partners’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$239K Sell
1,893
-38
-2% -$5.01K 0.01% 342
2026
Q1 		$269K Buy
1,931
+40
+2% +$5.6K 0.01% 274
2025
Q4 		$232K Sell
1,891
-188
-9% -$22.8K 0.01% 270
2025
Q3 		$231K Buy
2,079
+208
+11% +$23.6K 0.01% 257
2025
Q2 		$207K Buy
+1,871
New +$199K 0.02% 240

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Root Financial Partners's GILD Position: Q2 2026 in Review

Root Financial Partners reduced its Gilead Sciences (GILD) stake by 2% in Q2 2026, selling an estimated $5.01K and leaving 1,893 shares worth $239K. The position accounts for 0.01% of the portfolio, ranked #342.

Root Financial Partners first reported a position in GILD in Q2 2025 and has held it in 5 quarters since. The position peaked at $269K in Q1 2026. 2,283 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Root Financial Partners held 1,893 shares of Gilead Sciences worth $239K as of Q2 2026.
  • Root Financial Partners sold 38 Gilead Sciences shares in Q2 2026, an estimated $5.01K.
  • Gilead Sciences made up 0.01% of Root Financial Partners's portfolio in Q2 2026, its #342 holding.
  • Root Financial Partners first reported a position in Gilead Sciences in Q2 2025 and has held it in 5 quarters since.
  • Root Financial Partners's Gilead Sciences position peaked at $269K in Q1 2026.
  • 2,283 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Root Financial Partners's 13F filing for Q2 2026, filed 29 Jul 2026.